Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Supplementary data
Supplementary table 1. Outcomes at the last recorded visit in evaluable patients who were discontinued/terminated from the study for failing to attend hospital visits.
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Dataset |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Okamoto, Yoshitaka Kato, Moe Ishi, Kiyonori Sato, Yumi Hata, Tomohisa Asaka, Yuta |
| description | Supplementary table 1. Outcomes at the last recorded visit in evaluable patients who were discontinued/terminated from the study for failing to attend hospital visits. |
| doi_str_mv | 10.25402/imt.24166653 |
| format | Dataset |
| fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_25402_imt_24166653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_25402_imt_24166653</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_25402_imt_241666533</originalsourceid><addsrcrecordid>eNqVjz1OBDEMRtNQIKCk9wVmyPzsFLQIBJQsfeSdccAik4kSZ6WciGuSRcsBaOzC3_fkp9Rtp9t-N-r-jldp-7Gbpmk3XKrvPVqSAugXIGtpFj6Sp5Rgs4AwaA0vb_C55USw5CSwshCkfHDsPzI6EDw4kntYKM2Rw6kOY1MII1j2NYB1lMRnYNiSNCvGL5IKqKB4JHYO_UzAHl4xoG9hn0NwtJIXjAUWFLxWFxZdopvzvlLN0-P7w3NzOs71JxMiV24xnTa_oqaKmj_R4b_5H_OvY40</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Supplementary data</title><source>DataCite</source><creator>Okamoto, Yoshitaka ; Kato, Moe ; Ishi, Kiyonori ; Sato, Yumi ; Hata, Tomohisa ; Asaka, Yuta</creator><creatorcontrib>Okamoto, Yoshitaka ; Kato, Moe ; Ishi, Kiyonori ; Sato, Yumi ; Hata, Tomohisa ; Asaka, Yuta</creatorcontrib><description>Supplementary table 1. Outcomes at the last recorded visit in evaluable patients who were discontinued/terminated from the study for failing to attend hospital visits.</description><identifier>DOI: 10.25402/imt.24166653</identifier><language>eng</language><publisher>Taylor & Francis</publisher><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.25402/imt.24166653$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Okamoto, Yoshitaka</creatorcontrib><creatorcontrib>Kato, Moe</creatorcontrib><creatorcontrib>Ishi, Kiyonori</creatorcontrib><creatorcontrib>Sato, Yumi</creatorcontrib><creatorcontrib>Hata, Tomohisa</creatorcontrib><creatorcontrib>Asaka, Yuta</creatorcontrib><title>Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Supplementary data</title><description>Supplementary table 1. Outcomes at the last recorded visit in evaluable patients who were discontinued/terminated from the study for failing to attend hospital visits.</description><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqVjz1OBDEMRtNQIKCk9wVmyPzsFLQIBJQsfeSdccAik4kSZ6WciGuSRcsBaOzC3_fkp9Rtp9t-N-r-jldp-7Gbpmk3XKrvPVqSAugXIGtpFj6Sp5Rgs4AwaA0vb_C55USw5CSwshCkfHDsPzI6EDw4kntYKM2Rw6kOY1MII1j2NYB1lMRnYNiSNCvGL5IKqKB4JHYO_UzAHl4xoG9hn0NwtJIXjAUWFLxWFxZdopvzvlLN0-P7w3NzOs71JxMiV24xnTa_oqaKmj_R4b_5H_OvY40</recordid><startdate>20230920</startdate><enddate>20230920</enddate><creator>Okamoto, Yoshitaka</creator><creator>Kato, Moe</creator><creator>Ishi, Kiyonori</creator><creator>Sato, Yumi</creator><creator>Hata, Tomohisa</creator><creator>Asaka, Yuta</creator><general>Taylor & Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20230920</creationdate><title>Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Supplementary data</title><author>Okamoto, Yoshitaka ; Kato, Moe ; Ishi, Kiyonori ; Sato, Yumi ; Hata, Tomohisa ; Asaka, Yuta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_25402_imt_241666533</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Okamoto, Yoshitaka</creatorcontrib><creatorcontrib>Kato, Moe</creatorcontrib><creatorcontrib>Ishi, Kiyonori</creatorcontrib><creatorcontrib>Sato, Yumi</creatorcontrib><creatorcontrib>Hata, Tomohisa</creatorcontrib><creatorcontrib>Asaka, Yuta</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Okamoto, Yoshitaka</au><au>Kato, Moe</au><au>Ishi, Kiyonori</au><au>Sato, Yumi</au><au>Hata, Tomohisa</au><au>Asaka, Yuta</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Supplementary data</title><date>2023-09-20</date><risdate>2023</risdate><abstract>Supplementary table 1. Outcomes at the last recorded visit in evaluable patients who were discontinued/terminated from the study for failing to attend hospital visits.</abstract><pub>Taylor & Francis</pub><doi>10.25402/imt.24166653</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | DOI: 10.25402/imt.24166653 |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_datacite_primary_10_25402_imt_24166653 |
| source | DataCite |
| title | Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan. Supplementary data |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Okamoto,%20Yoshitaka&rft.date=2023-09-20&rft_id=info:doi/10.25402/imt.24166653&rft_dat=%3Cdatacite_PQ8%3E10_25402_imt_24166653%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |